PEPtalk2: results of a pilot randomised controlled trial to compare VZIG and aciclovir as postexposure prophylaxis (PEP) against chickenpox in children with cancer.
Bate J, Baker S, Breuer J, Chisholm JC, Gray J, Hambleton S, Houlton A, Jit M, Lowis S, Makin G, O'Sullivan C, Patel SR, Phillips R, Ransinghe N, Ramsay ME, Skinner R, Wheatley K, Heath PT.
Bate J, et al. Among authors: chisholm jc.
Arch Dis Child. 2019 Jan;104(1):25-29. doi: 10.1136/archdischild-2017-314212. Epub 2018 May 5.
Arch Dis Child. 2019.
PMID: 29730641
Clinical Trial.